Medicaretec Co., Ltd. – Trademark Portfolio

Entity Type: 03

Medicaretec Co., Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include YOMAG. The owner is based in Seoul.

H1-933AB

5, Hwarang-ro 14-gil, Seongbuk-gu

Seoul 02792 , KR

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

YOMAG
YOMAG
Registered 2024
YOMAG
YOMAG
Registered 2024

Trademark Classifications

Medicaretec Co., Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Medicaretec Co., Ltd. have?

Medicaretec Co., Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Medicaretec Co., Ltd. file in?

Medicaretec Co., Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 10 (Medical Apparatus). Class 35 covers advertising; business management; business administration; office functions.

What are Medicaretec Co., Ltd.'s most well-known trademarks?

Medicaretec Co., Ltd.'s registered trademark portfolio includes well-known marks such as YOMAG. These are among 2 currently registered trademarks in the portfolio.

What is Medicaretec Co., Ltd.'s trademark registration success rate?

Medicaretec Co., Ltd. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.